This protocol describes a non-viral method of delivery of genetic constructs to a certain area of living rodent brain. The method consists of plasmid preparation, micropipette fabrication, neonatal rat pup surgery, microinjection of the construct, and in vivo electroporation.
Creation of transgenic animals is a standard approach in studying functions of a gene of interest in vivo. However, many knockout or transgenic animals are not viable in those cases where the modified gene is expressed or deleted in the whole organism. Moreover, a variety of compensatory mechanisms often make it difficult to interpret the results. The compensatory effects can be alleviated by either timing the gene expression or limiting the amount of transfected cells.
The method of postnatal non-ventricular microinjection and in vivo electroporation allows targeted delivery of genes, siRNA or dye molecules directly to a small region of interest in the newborn rodent brain. In contrast to conventional ventricular injection technique, this method allows transfection of non-migratory cell types. Animals transfected by means of the method described here can be used, for example, for two-photon in vivo imaging or in electrophysiological experiments on acute brain slices.
1. Introduction
Creation of transgenic animals is a powerful method of investigation of gene functions in living animals1 and for unraveling disease mechanism2,3 as well as for manipulating properties of cells4. However, the procedure is rather laborious, extremely time consuming and expensive, thus warranting the use of alternative gene delivery methods such as viral injection5, neonatal ventricular injection with electroporation6 and in utero electroporation7,8. The method of postnatal non-ventricular injection and electroporation has a unique set of advantages: use of non-viral genetic constructs; possibility to create a local expression pattern in the area of interest; in situ transfection of non-migratory cell types, e.g. cortical astrocytes.
In this video, we demonstrate the detailed procedure of postnatal gene delivery to the neonatal rat brain using a plasmid encoding for the enhanced green fluorescent protein under chicken beta actin promoter with CMV enhancer (pCAG-EGFP)9. We illustrate the preparation of the plasmid-containing injection solution, manufacturing of thin glass pipettes and assembling of the microinjector on a stereotactic instrument. Then we talk about anaesthetizing rat pups with isoflurane, about performing the surgery, about the injection procedure and about the electroporation using forceps electrodes and the in vivo porator. Finally, we briefly discuss the anticipated results, perspectives and difficulties that may arise during these experiments.
2. Plasmid Preparation for Electroporation
3. Glass Needle Preparation
4. Microinjector Assembling
5. Anaesthetizing animal
All the procedures presented here were performed according to the University of Helsinki regulations for animal experiments.
6. Surgery, Microinjection and Electroporation
7. Representative Results
The expression of the transgene in the successfully transfected cells will appear approximately 10 hours after the electroporation, and it will remain stable for several weeks.
We microinjected the plasmid either into deep cortical layers or striatum region of postnatal day 2 (P2) Wistar rat pups and performed in vivo electroporation as described above. Brain slices (400 μm in thickness) were cut after 2 to 6 days (P4-P8) using a vibrotome in cold slicing medium (Hepes buffered Earle’s Balanced Salt Solution)10. Image acquisition was performed using Zeiss Axioplan 2 LSM5 Pascal confocal microscope (Zeiss, Germany) in the slicing medium at room temperature.
The injection sites in deep cortical layers and striatum contained many transfected cells expressing EGFP that were located in a compact region of approximately 200-300 μm in diameter (Figure 1A, B). Within transfected cells, the EGFP expression level is sufficiently high to allow imaging of thin cellular processes (Figure 1C) including dendrites with spines of different shapes (Figure 1D) and axon bundles (Figure 1E). The robust stability of EGFP as well as cell viability after electroporation allowed tracing distal parts of axons (up to 1.5-2 mm from cell bodies) such as cortical terminals (Figure 1F).
Figure 1. (A) Successfully transfected cells in the striatum region of P4 rat brain delineating the plasmid injection site. (B) Transfected cells in deep cortical layers (approximately 1000 μm below cortical surface) of P5 rat brain. (C) A transfected cell in the striatum region of P8 rat brain. (D) Dendritic processes of a transfected cell in the striatum region of P8 rat brain; arrows indicate different types of dendritic spines and filopodia. (E) Axons of transfected cells within collateral pathway. (F) Axons terminating at the pial surface of P8 rat cortex (arrowhead). Scale bars are 100 μm on A, B, E and F; 10 μm on C and D.
Methods of gene delivery into living rodent brain are well established for in utero electroporation7,8,11,12 and, more recently, for postnatal electroporation6. However, these methods are based on intraventricular injection of the plasmid DNA, which may be limiting for several applications. For example, these methods do not allow targeting cells in certain brain areas such as hippocampus, nor transfection of such non-migratory cell types as cortical astrocytes. Non-ventricular injection coupled with electroporation was first used for gene delivery into cerebellar neurons13. Our protocol illustrates the extension of non-ventricular method for other regions of rat brain. We propose that our methodological approach is a useful alternative to viral methods of gene delivery to restricted areas of interest within postnatal rat brain5.
Despite the advantages of the present method, some difficulties may be expected as discussed below.
1.Optimal age of animal
When possible, younger neonatal rat pups should be use, as a means to increase both transfection efficacy and pup survival after surgery. In our hands, the P0 pups are too small as it is difficult to target reproducibly a certain area in the brain using stereotactic coordinates obtained from the brain atlas available for this age14. In addition, the P0 pups have thin and tender skin that may impede sewing. The P3 and P4 are most convenient in terms of surgical and stereotactic manipulations as compared to P0-P2 animals, but they have hypersensitivity to isoflurane anesthesia that may cause seizures and breathing interruptions during surgery. Thus, the best option is P1-P2 rat pups which are predictable during surgery and large enough for reproducible microinjections.
2.Possible problems with microinjection
When small volumes of solution (25-100 nl) are injected through thin glass tip to the brain tissue exerts an opposing pressure, it is critical that air bubbles or leakages are carefully avoided. Failure to avoid these may cause a dramatic decrease in transfection efficiency.
3.Precision limits for stereotactic coordinates
Despite the precision of stereotactic coordinates, they have a limit at 0.3 mm reproducibility15. In our experience using animals of the same age and weight it is possible to decrease this limit to 0.2−0.1 mm which is sufficient for reproducible targeting of the CA1 hippocampal area.
We thank Ekaterina Karelina for help with soundtrack recording for the video, Ivan Molotkov for 3D animation and Dr. Peter Blaesse for CAG-EGFP plasmid preparation.
The work was supported by grants from the Centre of International Mobility of Finland, Finnish Cultural Foundation and the Academy of Finland.
Material Name | Type | Company | Catalogue Number | Comment |
---|---|---|---|---|
2A-sa dumb Tweezers, 115mm | equipment | XYtronic | XY-2A-SA | Treat with 70% ethanol for disinfection before use in surgical manipulations |
Biological Temperature Controller with stainless steel heating pad | equipment | Supertech | TMP-5b | |
Borosilicate tube with filament | material | Sutter Instruments | BF120-69-10 | Glass needle |
Disposable drills | material | Meisinger | HP 310 104 001 001 008 | |
Dulbeco’s PBS 10X | reagent | Sigma | D1408 | |
Dumont #5 forceps, 110 mm | equipment | FST | 91150-20 | Treat with 70% ethanol for disinfection before use in surgical manipulations |
Ealing microelectrode puller | equipment | Ealing | 50-2013 | Vertical electrode glass puller |
Ethilon monofil polyamide 6-0 FS-3 16 mm 3/8c | material | Johnson & Johnson Medical | EH7177H | Surgical threads |
Exmire micro syringe 10.0 ml | equipment | Exmire | MS*GLLX00 | Gas-tight syringe |
Fast Green | reagent | Sigma | F7252 | |
Forceps electrodes | equipment | BEX | LF650P3 | Treat with 70% ethanol for disinfection prior to use |
Foredom drill control | equipment | Foredom | FM3545 | Surgical drill power supply and control. Currently available analogue is micromotor kit K.1070 (Foredom) |
Foredom micro motor handpiece | equipment | Foredom | MH-145 | Currently available analogue is micromotor kit K.1070 (Foredom) |
Gas anesthesia platform for mice | equipment | Stoelting | 50264 | Assembled on stereotaxic instrument |
Isoflurane | reagent | Baxter | FDG9623 | |
Micro dressing forceps, 105 mm | equipment | Aesculap | BD302R | Treat with 70% ethanol for disinfection before use in surgical manipulations |
Microfil | material | WPI | MF34G-5 | Micro syringe filling capillaries |
Mineral oil | reagent | Sigma | M8410 | |
NanoFil Syringe 10 microliter | equipment | WPI | NANOFIL | Hamilton syringe |
plasmid CAG-EGFP | reagent | Extracted and purified with EndoFree Plasmid Maxi Kit (Qiagen) and dissolved in nuclease free water to concentration 1.5 mg/ml | ||
Pulse generator CUY21Vivo-SQ | equipment | BEX | CUY21Vivo-SQ | |
Schiller electrode gel | reagent | Schiller AG | 2.158000 | Conductive gel |
Small animal stereotaxic instrument | equipment | David Kopf Instruments | 900 | |
Stoelting mouse and neonatal rat adaptor | equipment | Stoelting | 51625 | Assembled on stereotaxic instrument. Treat earbars with 70% ethanol for disinfection before use in surgical manipulations |
Student iris scissors, straight 11.5 cm | equipment | FST | 91460-11 | Treat with 70% ethanol for disinfection before use in surgical manipulations |
Sugi absorbent swabs 17 x 8 mm | material | Kettenbach | 31602 | Surgical tampons |
UMP3 microsyringe pump and Micro 4 microsyringe pump controller | equipment | WPI | UMP3-1 | Microinjector and controller |
Univentor 400 Anesthesia Unit | equipment | Univentor | 8323001 |